Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Insider Profile

SBLENDORIO GLENN

Director, Officer | SEC CIK: 0001277478

Comprehensive Trading Performance Summary

The investment footprint of SBLENDORIO GLENN as disclosed via official SEC Form 4 filings provides a critical window into professional capital allocation strategies. By tracking this specific portfolio, investors can analyze how this individual moves capital across different boards and sectors. High-conviction moves by key stakeholders often serve as leading indicators for future market performance, as they reflect the intimate operational knowledge and fiduciary confidence of those closest to the company's decision-making process. Monitoring these strategic accumulation or exit patterns helps bridge the gap between institutional boardrooms and the retail investment community.

Filing Date Trade Date Ticker Company Name Industry Relationship Type Price Qty Total, $ Owned After Change, %
2023-01-05 02:34 2023-01-03 ISEE N/A Other Director, Officer - Chief Executive Officer OPT+S $20.06 17,447 $349,987 228,191 0.0%
2022-12-21 03:02 2022-12-19 ISEE N/A Other Director, Officer - CEO OPT+S $21.51 19,457 $418,520 244,138 0.0%
2022-11-05 00:01 2022-11-02 ISEE N/A Other Director, Officer - CEO SELL $23.01 50,000 $1,150,500 179,689 -21.8%
2022-04-07 01:11 2022-04-04 ISEE N/A Other Director, Officer - CEO SELL $18.76 50,000 $937,805 229,689 -17.9%
2022-04-02 02:03 2022-03-30 ISEE N/A Other Director, Officer - CEO OPT+S $17.47 43,369 $757,682 279,689 0.0%
2022-03-30 02:44 2022-03-25 ISEE N/A Other Director, Officer - CEO OPT+S $17.06 18,775 $320,302 279,689 0.0%
2022-03-22 23:43 2022-03-18 ISEE N/A Other Director, Officer - CEO OPT+S $17.00 3,479 $59,145 279,689 0.0%
2022-01-04 01:58 2021-12-30 ISEE N/A Other Director, Officer - CEO OPT+S $17.01 901 $15,322 279,133 0.0%
2021-12-28 04:58 2021-12-22 ISEE N/A Other Director, Officer - CEO OPT+S $16.76 58,476 $979,906 279,133 0.0%
2021-12-22 02:02 2021-12-20 ISEE N/A Other Director, Officer - CEO OPT+S $15.44 18,524 $286,075 339,133 0.0%
2021-12-15 02:07 2021-12-13 ISEE N/A Other Director, Officer - Chief Executive Officer OPT+S $14.74 8,293 $122,279 320,999 0.0%
2019-12-12 02:54 2019-12-10 ISEE N/A Other Director, Officer - President and CEO BUY $4.00 62,500 $250,000 176,854 +54.7%
2019-11-19 01:45 2019-11-15 ISEE N/A Other Director, Officer - President and CEO BUY $3.12 15,000 $46,851 114,354 +15.1%
2019-05-13 23:09 2019-05-10 ISEE N/A Other Director, Officer - President and CEO BUY $1.48 25,000 $37,000 93,105 +36.7%
2019-04-04 01:11 2019-04-02 OPHT N/A Other Director, Officer - President and CEO OPT+S $1.43 6,914 $9,887 68,105 0.0%
2018-04-04 02:06 2018-04-02 OPHT N/A Other Officer - President and CEO OPT+S $2.69 6,838 $18,394 48,407 0.0%
2018-01-04 01:01 2018-01-02 OPHT N/A Other Director, Officer - President and CEO OPT+S $3.19 8,089 $25,804 36,495 0.0%
2017-07-06 01:31 2017-07-05 OPHT N/A Other Director, Officer - President and CEO OPT+S $2.58 7,828 $20,196 24,164 0.0%
2017-04-05 02:10 2017-04-03 OPHT N/A Other Officer - President, CFO and Treasurer OPT+S $3.56 7,388 $26,301 11,572 0.0%
2016-12-24 01:05 2016-12-22 OPHT N/A Other Officer - EVP, COO & CFO, Treasurer SELL $4.85 1,079 $5,236 0 -100.0%
2016-06-04 01:28 2016-06-02 OPHT N/A Other Officer - EVP, COO & CFO, Treasurer OPT+S $57.20 671 $38,381 1,079 0.0%
2016-01-05 01:35 2015-12-30 OPHT N/A Other Director OPT+S $80.00 2,000 $160,000 0 0.0%
2015-09-04 23:17 2015-09-03 MDCO N/A Other Director, Officer - President & CFO OPT+S $42.00 25,000 $1,050,000 99,805 0.0%
2015-09-03 01:44 2015-08-31 MDCO N/A Other Director, Officer - President & CFO OPT+S $39.75 114,495 $4,551,600 99,805 0.0%
2015-07-21 00:19 2015-07-16 OPHT N/A Other Director OPT+S $67.33 3,000 $202,000 0 0.0%
2015-07-21 00:19 2013-09-30 OPHT N/A Other Director BUY $22.00 1,000 $22,000 1,000 +100.0%
2015-07-16 00:03 2015-07-13 FOLD AMICUS THERAPEUTICS, INC. Pharmaceutical Preparations Director OPT+S $15.00 10,000 $150,000 11,933 0.0%
2015-06-27 01:09 2015-06-25 MDCO N/A Other Director, Officer - President & CFO SELL $32.00 3,305 $105,760 99,539 -3.2%
2015-04-18 00:02 2015-04-15 FOLD AMICUS THERAPEUTICS, INC. Pharmaceutical Preparations Director OPT+S $12.50 20,000 $250,000 11,933 0.0%
2015-03-26 00:00 2015-03-23 MDCO N/A Other Director, Officer - President & CFO SELL $30.78 34,773 $1,070,316 102,844 -25.3%
2014-08-29 23:52 2014-08-27 FOLD AMICUS THERAPEUTICS, INC. Pharmaceutical Preparations Director OPT+S $6.50 10,000 $65,000 11,933 0.0%
2014-08-29 23:52 2014-08-27 FOLD AMICUS THERAPEUTICS, INC. Pharmaceutical Preparations Director BUY $6.50 10,000 $65,000 21,933 +83.8%
2013-12-07 01:05 2013-12-04 MDCO N/A Other Director, Officer - President & CFO OPT+S $38.50 8,516 $327,866 118,405 0.0%
2013-11-21 01:04 2013-11-18 MDCO N/A Other Director, Officer - President & CFO OPT+S $38.50 16,484 $634,634 118,405 0.0%
2013-11-19 01:02 2013-11-14 MDCO N/A Other Director, Officer - President & CFO SELL $38.00 1,667 $63,346 118,405 -1.4%
2013-10-29 23:35 2013-10-25 MDCO N/A Other Director, Officer - President & CFO OPT+S $35.69 25,574 $912,851 120,072 0.0%
2013-05-13 23:48 2013-05-10 MDCO N/A Other Director, Officer - President & CFO SELL $37.00 2,709 $100,233 120,434 -2.2%
2013-02-27 00:13 2013-02-25 MDCO N/A Other Director, Officer - President & CFO SELL $31.11 6,613 $205,741 85,324 -7.2%
2013-02-23 00:14 2013-02-20 MDCO N/A Other Director, Officer - President & CFO SELL $32.42 2,793 $90,549 91,937 -2.9%
2013-02-22 00:34 2013-02-19 MDCO N/A Other Director, Officer - Executive VP & CFO OPT+S $32.45 27,552 $893,930 94,730 0.0%
2013-01-18 00:23 2013-01-16 MDCO N/A Other Director, Officer - President & CFO OPT+S $30.00 125,000 $3,750,000 97,282 0.0%
2013-01-11 00:14 2013-01-08 MDCO N/A Other Director, Officer - President & CFO OPT+S $28.07 25,000 $701,750 97,282 0.0%
2012-08-14 23:01 2012-08-10 MDCO N/A Other Director, Officer - President & CFO OPT+S $25.13 33,989 $854,283 96,877 0.0%
2012-07-27 23:02 2012-07-25 MDCO N/A Other Director, Officer - President & CFO OPT+S $25.15 25,000 $628,750 105,866 0.0%
2012-03-21 23:01 2012-03-19 MDCO N/A Other Director, Officer - President & CFO OPT+S $20.39 625 $12,744 105,866 0.0%
2012-02-24 00:02 2012-02-21 MDCO N/A Other Director, Officer - Executive VP & CFO OPT+S $20.95 4,744 $99,396 62,483 0.0%
2012-01-21 00:08 2012-01-19 MDCO N/A Other Director, Officer - Executive VP & CFO OPT+S $19.38 625 $12,113 66,602 0.0%
2011-12-22 00:05 2011-12-19 MDCO N/A Other Director, Officer - Executive VP & CFO OPT+S $19.50 625 $12,188 66,602 0.0%
2011-11-23 00:03 2011-11-21 MDCO N/A Other Director, Officer - Executive VP & CFO OPT+S $17.81 625 $11,131 66,602 0.0%
2011-11-17 00:23 2011-11-14 MDCO N/A Other Director, Officer - Executive VP & CFO SELL $19.50 3,635 $70,883 66,602 -5.2%
SHOW ENTRIES

Tracking Multi-Role Insiders: SBLENDORIO GLENN

High-level stakeholders like SBLENDORIO GLENN, whether acting as directors, officers, or 10% owners, often possess unique cross-sector insights. Monitoring a specific CIK like 0001277478 allows investors to identify recurring patterns of trading success across various industries. When a large 10% shareholder or a key beneficial owner moves capital, it often signals a strategic shift in institutional or private conviction.

SEC Transparency for Key Stakeholders

Every market move made by SBLENDORIO GLENN is a matter of public record under federal law. By aggregating Form 4 filings, we provide transparency into the portfolios of major players who hold significant influence. Following the money of those with a 10% stake or executive power helps bridge the information gap between the boardroom and the retail investor.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.